Wang D M, Dubendorff J W, Woo C H, Lipsick J S
Department of Pathology, Stanford University School of Medicine, Stanford, California 94305-5324, USA.
J Virol. 1999 Jul;73(7):5875-86. doi: 10.1128/JVI.73.7.5875-5886.1999.
The c-myb gene is implicated in the differentiation and proliferation of hematopoietic cells. Truncations of the N and/or C terminus of c-Myb, found in v-Myb, can potentiate its transforming ability. Two negative regulatory subregions, located in the C terminus, were mapped previously by using GAL4-c-Myb fusion proteins in transient transfection assays for the transcriptional activation of a GAL4-responsive reporter gene. To dissect the C terminus of c-Myb in terms of its involvement in transcriptional activation and oncogenic transformation, a series of C-terminal deletion mutants of c-Myb were analyzed. In addition, linker insertion mutants within the transactivation domain and/or heptad leucine repeat of c-Myb were examined along with those deletion mutants. In this study, we demonstrated that the removal of both of the two previously mapped negative regulatory subregions from the native form of c-Myb not only supertransactivates a Myb-responsive reporter gene but also potentiates its transforming ability in culture. However, in contrast to previous results, cells transformed by all of the mutants analyzed here except v-Myb itself exhibited the same phenotype as those transformed by c-Myb. The proliferating cells were bipotenial and differentiated into both the granulocytic and monocytic lineages. This result implies that the C terminus of c-Myb alone has no effect on the lineage determination. Finally, the transactivation activities of these mutants correlated with their transforming activities when a mim-1 reporter gene was used but not when a model promoter containing five tandem Myb-binding sites was used. In particular, a very weakly transforming mutant with a linker insertion in the heptad leucine repeat superactivated the model promoter but not the mim-1 reporter gene.
c-myb基因与造血细胞的分化和增殖有关。在v-Myb中发现的c-Myb的N端和/或C端截短可增强其转化能力。以前通过在瞬时转染实验中使用GAL4-c-Myb融合蛋白来转录激活GAL4反应性报告基因,绘制了位于C端的两个负调控亚区域。为了从c-Myb的C端参与转录激活和致癌转化方面进行剖析,分析了一系列c-Myb的C端缺失突变体。此外,还研究了c-Myb的反式激活结构域和/或七肽亮氨酸重复序列内的接头插入突变体以及那些缺失突变体。在本研究中,我们证明从c-Myb的天然形式中去除两个先前绘制的负调控亚区域,不仅能超级激活Myb反应性报告基因,还能增强其在培养中的转化能力。然而,与先前的结果相反,除v-Myb本身外,这里分析的所有突变体转化的细胞表现出与c-Myb转化的细胞相同的表型。增殖细胞具有双潜能,可分化为粒细胞系和单核细胞系。这一结果表明,单独的c-Myb的C端对谱系决定没有影响。最后,当使用mim-1报告基因时,这些突变体的反式激活活性与其转化活性相关,但当使用含有五个串联Myb结合位点的模型启动子时则不相关。特别是,在七肽亮氨酸重复序列中插入接头的一个转化能力非常弱的突变体超级激活了模型启动子,但没有超级激活mim-1报告基因。